ArticleClinical and molecular hepatology2022

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma.

Hideki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.